机译:造血干细胞动员是必要的,但对胰岛移植的耐受性并不足够。
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN;
Department of Pediatrics, (I)an Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN;
Department of Pediatrics, (I)an Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN;
Departartment of Pharmacology, Vanderbilt University Medical Center, Nashville, TN;
Department of Pediatrics, (I)an Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN;
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN;
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN,Department of Pediatrics, (I)an Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, TN;
机译:同种异体造血干细胞移植诱导小鼠异体移植耐受性和存活时间的延长
机译:胰岛和造血干细胞联合异体移植:诱导嵌合和移植耐受性的临床试验。
机译:在异基因造血干细胞移植供体的CD34(+)外周血造血干细胞动员程序中评估原始非格司亭(Neupogen(R)),生物仿制药非格司亭(Leucostim(R))和Lenograstim(Granocyte(R))的功效和安全性
机译:造血干细胞移植跨重大遗传障碍:Megadose CD34细胞和其他否决细胞的耐受性诱导
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:造血干细胞动员是必要的但对胰岛移植的耐受性并不足够。
机译:基于BioSimilar G-CSF的外周血造血干细胞动员,用于自体和同种异体干细胞移植